---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-012080"
form_type: "8-K"
ticker: null
cik: "0000849636"
company_name: "RespireRx Pharmaceuticals Inc."
filed_at: "2023-04-13T23:59:59+00:00"
generated_at: "2026-06-17T02:52:42.867226+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# RespireRx issues Series J preferred to settle $570K of officer/vendor liabilities

## Summary
- Exchanged $570K of accrued compensation/debt for 5,700 shares of Series J 8% voting preferred stock.
- Margolis (CFO) and Lippa (Interim CEO) each received 2,100 shares; vendor Radin received 1,500 shares.
- Series J shares have $100 stated value, 8% annual dividend payable in stock, and 100x voting rights.
- Redemption triggers include upfront payments, milestones, or royalties ≥$20M; liquidation preference before common.
- Shares transferred immediately to trusts/affiliates; unregistered offering under Section 4(a)(2).

## SEC filing metadata
- accession: 0001493152-23-012080
- form_type: 8-K
- cik: 0000849636
- company_name: RespireRx Pharmaceuticals Inc.
- filed_at: 2023-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/849636/000149315223012080/0001493152-23-012080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/849636/000149315223012080/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-012080
- JSON: https://secwatch.observer/filing/0001493152-23-012080.json
- Plain text: https://secwatch.observer/filing/0001493152-23-012080.txt

## Key facts
- Governance Changes
  RespireRx Pharmaceuticals Inc.: Amendment to certificate of incorporation to establish Series J 8% Voting, Participating, Redeemable Preferred Stock (effective 2023-04-12).
  - Change: charter amendment
  - Effective: 2023-04-12
  source text: On April 11, 2023 , the Company’s Board of Directors authorized an amendment to the Company’s certificate of incorporation to establish a Series J 8% Voting, Participating, Redeemable Preferred Stock (Series J Certificate of Designation”). On April 12, 2023, the Company filed the Series J Certificate of Designation with the Secretary of State of the state of Delaware.
  evidence_url: https://www.sec.gov/Archives/edgar/data/849636/000149315223012080/0001493152-23-012080-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.